NIH harnessed AI for COVID-19 diagnosis, treatment, and monitoring
On Aug. 5, 2020, the National Institutes of Health (NIH) announced it had launched the Medical Imaging and…
-
-
BioNTech and Fosun Pharma announced start of clinical trial of mRNA-based COVID-19 vaccine candidate in China
On Aug. 5, 2020, BioNTech and Shanghai Fosun Pharmaceutical announced that the first 72 participants had been dosed…
-
Mateon and Abiogenesis to initiate clinical study to test Artemisinin as a treatment for COVID-19 in India
On Aug. 4, 2020, Mateon Therapeutics and Abiogenesis announced they will be working together with Abiogenesis to initiate…
-
Novavax announced positive phase 1 data for its COVID-19 vaccine candidate
On Aug. 4, 2020, Novavax announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of…
-
Oxford University and ZOE partnered on COVID-19 treatment trials
On Aug. 3, 2020, the University of Oxford and the COVID Symptom Study joined forces to widen access…
-
Members of the COVID R&D alliance and quantum leap healthcare collaborative enrolled first patients in I-SPY COVID trial
On Aug. 3, 2020, members of the COVID R&D Alliance AbbVie, Amgen and Takeda Pharma announced the first…
-
Lilly initiated phase 3 trial of LY-CoV555 for prevention of COVID-19 at Long-term care facilities in partnership with NIAID
On Aug. 3, 2020, Eli Lilly announced the initiation of BLAZE-2, a phase 3 trial studying LY-CoV555 for…
-
Atossa Therapeutics received approval to open clinical study of AT-301 nasal spray being developed to treat COVID-19
On Aug. 3, 2020, Atossa Therapeutics announced that it had received approval from the ethics committee to open…
-
OraSure’s OMNIgene-ORAL device included in EUA granted to Clinical Reference Laboratory for self-collected SARS saliva test
On Jul. 31, 2020, OraSure Technologies announced that its OMNIgene-ORAL (OM-505) saliva collection device is included in the…
-
RedHill Biopharma initiated global phase 2/3 study for COVID-19
On Jul. 30, 2020, RedHill Biopharma announced that it has initiated a global Phase 2/3 clinical study evaluating…
-
Apogenix started European clinical phase II trial with Asunercept in COVID-19 patients
On Jul. 28, 2020, Apogenix announced that it had received regulatory approval to start a clinical phase II…
-
Serum Institute conducted phase III clinical trial of BCG vaccine
On Jul. 27, 2020, the Serum Institute of India announced that it was is conducting phase III clinical…
-
Onconova Therapeutics submitted application for rigosertib to participate in federally funded human studies in COVID-19 disease
On Jul. 27, 2020, Onconova Therapeutics announced that it had submitted an application with the National Institute of…
-
Biotechnology | Clinical Research | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
CIRM board approved two new discovery research projects for COVID-19
On Jul. 24, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two new…
-
COVID-19 vaccine trials conducted at Washington University, Saint Louis University
On Jul. 21, 2020, researchers at Washington University School of Medicine in St. Louis and the Saint Louis…
-
COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
On Jul. 20, 2020, AstraZeneca announced that Interim results from the ongoing Phase I/II COV001 trial, led by…
-
Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTI for treatment of COVID-19
On Jul. 16, 2020, Heron Therapeutics announced the initiation of the GUARDS-1 Study, a Phase 2 clinical study…
-
Biotechnology | Clinical Research | Diagnostics | FDA | Medical Device | Non-Profit Research | Oncology | Rare Disease | Stem Cell | Therapeutics | U.S. Congress
Tufts Center for the Study of Drug Development reported faster new drug approval times were more than offset by longer clinical Times in US
On Jul. 16, 2020, the Tufts Center for the Study of Drug Development reported that although regulatory approval…
-
Biotechnology | Clinical Research | COVID-19 | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine
NIH launched clinical trials network to test COVID-19 vaccines and other prevention tools
On Jul. 8, 2020, the National Institute of Allergy and Infectious Diseases announced it had established a new…
-
Regeneron announced start of REGN-COV2 phase 3 COVID-19 prevention trial in collaboration with National Institute of Allergy and Infectious Diseases
On Jul. 6, 2020, Regeneron announced the initiation of late-stage clinical trials evaluating REGN-COV2, Regeneron’s investigational double antibody…
-
Mylan secured regulatory approval for remdesivir lyophilized powder for injection 100 mg/vial in India for restricted emergency use in COVID-19 patients
On Jul. 6, 2020, Mylan announced that the Drug Controller General of India (DCGI) has approved its remdesivir…
-
Abivax treated first patient in phase 2b/3 ABX464 Covid-19 clinical trial
On Jul. 2, 2020, French biotech company Abivax announced it had has treated the first patient in a…
-
Regeneron and Sanofi announced Kevzara (sarilumab) phase 3 US trial in COVID-19 patients did not meet endpoints
On Jul. 2, 2020, Regeneron and Sanofi announced that the U.S. Phase 3 trial of Kevzara (sarilumab) 400…
-
Pfizer and BioNTech announced early positive data from ongoing phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…
-
Bharat Biotech COVID-19 vaccine – COVAXIN received DCGI approval for phase I & II Human clinical trials
On Jun. 29, 2020, Bharat Biotech announced it had successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19,…
-
Symbiosis and AstraZeneca signed supply agreement for sterile manufacture of COVID-19 vaccine for clinical trials
On Jun. 24, 2020, Symbiosis Pharmaceutical Services, an India-based specialist provider of pharmaceutical and vaccine development services, announced…
-
The FDA announced first of its kind pilot program to communicate patient reported outcomes from cancer clinical trials
On Jun. 23, 2020, the U.S. Food and Drug Administration today launched Project Patient Voice, an initiative of…
-
FibroGen announced first patient enrolled in Pamrevlumab clinical trial in patients hospitalized in US with acute COVID-19
On Jun. 23, 2020, FibroGen announced it has started enrollment for a Phase II clinical trial of pamrevlumab…
-
Mateon selected IQVIA for its randomized, controlled, multi-menter clinical study to test OT-101 as treatment for COVID-19 patients
On Jun. 23, 2020, Mateon Therapeutics, a leading developer of TGF-β therapeutics, announced it has selected IQVIA to…
-
Pfizer announced start of four phase 3 clinical trials for investigational vaccines
On Jun. 22, 2020, Pfizer announced the initiation of four phase 3 clinical trials within its current pipeline…
